Treatment Response Rates Following a Myeloma Relapse

patientpower has 2403 videos Subscribe Here

Description: Will certain myeloma drugs respond well if used again for relapse? A patient poses a question about relapse and whether Lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasonealone (Decadron) in combination can be used to retreat myeloma. Myeloma expert Dr. Robert Orlowski answers by talking about various studies and examples of patients who responded favorably to Velcade as a stand-alone therapy, then did well when retreated with Velcade once again. Dr. Orlowski speaks about the potential response from the retreatment with various agents, but also points to the potential for resistance.
Produced in association with MD Anderson Cancer Center

Get email alerts | http://www.patientpower.inf...

Subscribe on YouTube |
Like on Facebook |
Follow on Twitter |
Shared By : patientpower
Posted on : 12/12/13
Added : 4 years ago
Category : General